REDHILL BIOPHARMA LTD. Current Accrued Expenses And Other Current Liabilities
REDHILL BIOPHARMA LTD. (RDHL) had Current Accrued Expenses And Other Current Liabilities of $10.69 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2025-09-05
- 2025-06-30: Current Accrued Expenses And Other Current Liabilities $10.69M.
- 2024-12-31: Current Accrued Expenses And Other Current Liabilities $9.99M.
- 2024-06-30: Current Accrued Expenses And Other Current Liabilities $3.96M.
- 2023-12-31: Current Accrued Expenses And Other Current Liabilities $4.59M.
| Period end | Current Accrued Expenses And Other Current Liabilities | Current Accrued Expenses And Other Current Liabilities as first filed |
|---|---|---|
| 2025-06-30 | $10.69M 6-K · filed 2025-09-05 | |
| 2024-12-31 | $9.99M 6-K · filed 2025-09-05 | |
| 2024-06-30 | $3.96M 6-K · filed 2024-08-29 | |
| 2023-12-31 | $4.59M 20-F · filed 2025-04-10 | |
| 2023-06-30 | $7.40M 6-K · filed 2023-08-17 | |
| 2022-12-31 | $17.95M 20-F · filed 2024-04-08 | |
| 2022-06-30 | $20.21M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $20.90M 20-F · filed 2023-04-28 | |
| 2021-06-30 | $23.16M 6-K · filed 2021-08-26 | |
| 2020-12-31 | $24.08M 20-F · filed 2022-03-17 | |
| 2020-06-30 | $29.19M 6-K · filed 2020-08-13 | |
| 2019-12-31 | $4.33M 20-F · filed 2021-03-18 | $5.60M 20-F · filed 2020-03-04 |
| 2019-06-30 | $8.46M 6-K · filed 2019-07-23 | |
| 2018-12-31 | $7.06M 20-F · filed 2020-03-04 | |
| 2018-06-30 | $5.35M 6-K · filed 2018-08-30 | |
| 2017-12-31 | $6.03M 20-F · filed 2019-02-26 | |
| 2016-12-31 | $3.30M 20-F · filed 2018-02-22 |